As we enter 2024, the forecast for HIV-AIDS mortality among women in Germany reflects stability, with standardised rates consistently projected to be at 100 deaths per hundred thousand women annually until 2028. In comparison to 2023 data, which presented similar figures, there is no anticipated change or variation in year-on-year mortality rates over the forecast period. This stability implies a lack of significant trends or unusual deviations, and the five-year compound annual growth rate (CAGR) also suggests no variance.
Future trends to observe include advancements in HIV treatment and prevention strategies, which could potentially lower mortality rates. Additionally, demographic changes or healthcare policy adjustments in Germany might influence long-term trends.